Group One Trading’s IGC Pharma IGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-7,600
Closed -$3.17K 8595
2025
Q3
$3.17K Buy
+7,600
New +$2.89K ﹤0.01% 7747
2024
Q1
Sell
-600
Closed -$168 7448
2023
Q4
$168 Hold
600
﹤0.01% 7171
2023
Q3
$216 Sell
600
-3,200
-84% -$1.14K ﹤0.01% 7422
2023
Q2
$1.18K Hold
3,800
﹤0.01% 7225
2023
Q1
$1.29K Sell
3,800
-31,900
-89% -$12K ﹤0.01% 6724
2022
Q4
$11.4K Sell
35,700
-4,600
-11% -$1.88K ﹤0.01% 5965
2022
Q3
$17K Buy
40,300
+1,800
+5% +$959 ﹤0.01% 6175
2022
Q2
$20K Sell
38,500
-6,400
-14% -$4.04K ﹤0.01% 6285
2022
Q1
$43K Buy
44,900
+6,400
+17% +$6.22K ﹤0.01% 6202
2021
Q4
$38K Sell
38,500
-22,000
-36% -$29.5K ﹤0.01% 6531
2021
Q3
$90K Sell
60,500
-9,900
-14% -$16K ﹤0.01% 6015
2021
Q2
$115K Buy
70,400
+19,600
+39% +$29.9K ﹤0.01% 5820
2021
Q1
$91K Buy
50,800
+7,900
+18% +$14.4K ﹤0.01% 5743
2020
Q4
$67K Sell
42,900
-19,400
-31% -$28.7K ﹤0.01% 4819
2020
Q3
$65K Buy
+62,300
New +$63.3K ﹤0.01% 4469
2019
Q4
Sell
-33,500
Closed -$33K 5320
2019
Q3
$33K Sell
33,500
-23,800
-42% -$28.6K ﹤0.01% 4170
2019
Q2
$94K Buy
57,300
+51,300
+855% +$72.5K ﹤0.01% 3402
2019
Q1
$12K Buy
+6,000
New +$13.6K ﹤0.01% 4208

Other funds holding IGC

Group One Trading's IGC Position: Q1 2026 in Review

Group One Trading reduced its IGC Pharma (IGC) stake by 48% in Q1 2026, selling an estimated $950 and leaving 3,762 shares worth $989. The position accounts for ﹤0.01% of the portfolio, ranked #7215.

Group One Trading first reported a position in IGC in Q4 2019 and has held it in 24 quarters since. The position peaked at $99K in Q1 2021. 35 funds tracked by Wall St. Rank hold IGC as of Q1 2026.

  • Group One Trading held 3,762 shares of IGC Pharma worth $989 as of Q1 2026.
  • Group One Trading sold 3,425 IGC Pharma shares in Q1 2026, an estimated $950.
  • IGC Pharma made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7215 holding.
  • Group One Trading first reported a position in IGC Pharma in Q4 2019 and has held it in 24 quarters since.
  • Group One Trading's IGC Pharma position peaked at $99K in Q1 2021.
  • 35 funds tracked by Wall St. Rank held IGC Pharma as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.